UK tribunal backs CMA in “extremely serious” excessive pricing case

The UK’s antitrust authority rightly fined Auden McKenzie and Actavis UK for inflating the price of hydrocortisone by over 10,000% but was wrong to sanction another company as part of its decision, the Competition Appeal Tribunal has ruled.

Unlock unlimited access to all Global Competition Review content